Search Results - "Massonnet, Gerald"
-
1
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists
Published in Nature (London) (17-09-2015)“…Although imatinib gives good clinical results in chronic myeloid leukaemia (CML), residual disease attributed to quiescent CML stem cells remains in many…”
Get full text
Journal Article -
2
Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient‐derived xenografts
Published in Pigment cell and melanoma research (01-05-2017)“…Summary Monoclonal antibodies specific for biomarkers expressed on the surface of uveal melanoma (UM) cells would simplify the immune capture and genomic…”
Get full text
Journal Article -
3
Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization
Published in PloS one (07-07-2016)“…Drug discovery efforts have focused on the tumor microenvironment in recent years. However, few studies have characterized the stroma component in…”
Get full text
Journal Article -
4
Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters
Published in Laboratory investigation (01-05-2013)“…Metabolic adaptations and changes in the expression of nutrient transporters are known to accompany tumorigenic processes. Nevertheless, in the context of…”
Get full text
Journal Article -
5
Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds
Published in BMC cancer (04-12-2014)“…The B-subunit of Shiga toxin (STxB) specifically binds to the glycosphingolipid Gb3 that is highly expressed on a number of human tumors and has been shown to…”
Get full text
Journal Article -
6
Evaluating patient-derived colorectal cancer xenografts as preclinical models by comparison with patient clinical data
Published in Cancer research (Chicago, Ill.) (15-04-2015)“…Development of targeted therapeutics required translationally relevant preclinical models with well-characterized cancer genome alterations. Here, by studying…”
Get full text
Journal Article -
7
Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Published in Oncotarget (24-04-2018)“…The prognosis of metastatic uveal melanoma (UM) is among the worst of all human cancers. The identification of near-ubiquitous GNAQ/GNA11 mutations and the…”
Get full text
Journal Article -
8
High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a
Published in Blood (15-09-2006)“…V617F JAK2 mutation is a reliable molecular marker of polycythemia vera (PV), potentially useful to monitor the effect of treatments in this disease. In a…”
Get full text
Journal Article -
9
High molecular response rate of polycythemia vera patients treated with pegylated interferon α–2a
Published in Blood (15-09-2006)“…V617F JAK2 mutation is a reliable molecular marker of polycythemia vera (PV), potentially useful to monitor the effect of treatments in this disease. In a…”
Get full text
Journal Article -
10
Abstract 5782: Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Purpose: The prognosis of metastatic uveal melanoma (UM) patients remains one of the worst observed in human cancers. The identification of frequently…”
Get full text
Journal Article -
11
Abstract 2087: The MEK1/2 inhibitor selumetinib (AZD6244; ARRY-142886) appears as an efficient targeted therapy when used in an adjuvant setting in patient-derived xenografts of uveal melanoma
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Uveal melanomas (UM) constitute the most common primary intraocular tumors in adults and are characterized by a constitutive activation of the MAPK…”
Get full text
Journal Article -
12
Abstract B142: Dissociation of preclinical primary human cancer xenografts for cell surface transportome profiling
Published in Molecular cancer therapeutics (12-11-2011)“…Abstract Background: Tumor cell metabolism is of growing interest in both basic and clinical cancer research. A better understanding of underlying molecular…”
Get full text
Journal Article -
13
The V617F JAK2 Mutation Is Very Uncommon in Idiopathic Erythrocytosis
Published in Blood (16-11-2006)“…The V617F JAK2 mutation is highly frequent in Polycythemia Vera (PV) patients. Indeed, we and others found the mutation in 70 to 90% of PV patients. However…”
Get full text
Journal Article -
14
Abstract POSTER-THER-1404: in vivo synergism between chemotherapy and the 3C23K monoclonal antibody directed against the anti-müllerian hormone type II receptor in ovarian cancer patient-derived xenografts
Published in Clinical cancer research (15-08-2015)“…Abstract Purpose of the study: Müllerian inhibiting substance, also called anti-Müllerian hormone (AMH), belongs to the TGF-β family and plays a key role…”
Get full text
Journal Article -
15
Erosion of the chronic myeloid leukaemia stem cell pool by PPAR[gamma] agonists
Published in Nature (London) (17-09-2015)“…Whether cancer is maintained by a small number of stem cells or is composed of proliferating cells with approximate phenotypic equivalency is a central…”
Get full text
Journal Article -
16
Erosion Of The Chronic Myeloid Leukemia Stem Cell Pool By PPARγ Agonists
Published in Blood (15-11-2013)“…Whether cancer is maintained by a small number of stem cells or is composed of proliferating cells with approximate phenotypic equivalency is a central…”
Get full text
Journal Article -
17
The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages
Published in Oncotarget (21-11-2017)“…Müllerian inhibiting substance, also called anti-Müllerian hormone (AMH), inhibits proliferation and induces apoptosis of AMH type II receptor-positive tumor…”
Get full text
Journal Article -
18
Abstract LB-161: Colospheres: 3D ex vivo microtumors with more aggressive phenotype than original human colon cancer tissues
Published in Cancer research (Chicago, Ill.) (15-04-2010)“…Abstract The ex vivo colospheres are a newly characterised three-dimensional colon cancer multicellular model, derived from mechanically dissociated human…”
Get full text
Journal Article